Davidson v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
Consolidated
Lead case: 9:20-md-02924
Lead case: 9:20-md-02924
Florida Southern District Court | |
Judge: | Robin L Rosenberg |
Case #: | 9:21-cv-81833 |
Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
Cause | 28:1332 Diversity-(Citizenship) |
Case Filed: | Sep 29, 2021 |
Terminated: | Oct 07, 2021 |
Case in other court: | Tennessee Eastern, 1:21-cv-00210 |
Last checked: Monday Mar 28, 2022 5:31 AM EDT |
Defendant
Boehringer Ingelheim Pharmaceuticals, Inc.
|
Represented By
|
Defendant
John Does 1-100 Inclusive
|
|
Defendant
GlaxoSmithKline LLC
|
Represented By
|
Plaintiff
Buford Farris Davidson
|
Represented By
|
Docket last updated: 11 hours ago |
Friday, September 16, 2022 | ||
12 | 12
order
Administrative Order ~Util - Terminate Case Associations
Mon 09/19 12:33 PM
ORDER Deconsolidated Cases. This case is DECONSOLIDATED from MDL proceeding 20-MD-2924. Case shall remain CLOSED. Signed by Judge Robin L. Rosenberg on 9/16/2022. See attached document for full details. (pes) |
|
Thursday, June 30, 2022 | ||
11 | 11
notice
Notice of Voluntary Dismissal - aty
Thu 06/30 5:38 PM
NOTICE of Voluntary Dismissal WITHOUT PREJUDICE by Buford Farris Davidson. Attorney T. Roe Frazer, II added to party Buford Farris Davidson(pty:pla). (Frazer, T.) |
|
Thursday, October 07, 2021 | ||
10 | 10
order
Administrative Order
Thu 10/07 11:41 AM
ORDER OF CONSOLIDATION AND ADMINISTRATIVE CLOSE-OUT. Signed by Judge Robin L. Rosenberg on 10/7/2021. See attached document for full details. (mc) |
|
Wednesday, September 29, 2021 | ||
9 | 9 MDL Transfer In Case Receipt from Eastern District of Tennessee. Case Number 1:21-cv-00210 with documents 1-6. Assigned FLSD Case Number 9:21-cv-81833-RLR Davidson v. Boehringer Ingelheim Pharmaceuticals, Inc. et al on 9/29/2021. Re: FLSD MDL Case Number 9:20-md-02924-RLR pursuant to Conditional Transfer Order 77. Clerks Note: JPML notified (mc) | |
8 | 8 Clerks Notice of Judge Assignment to Judge Robin L. Rosenberg. (mc) | |
7 | 7
transfer
Case Transferred In - District Transfer - CV - NO FEE
Wed 09/29 3:57 PM
Case transferred in from Tennessee Eastern; Case Number 1:21-cv-00210. Electronic file including transfer order and docket sheet received. .(mc) |
|
order
Clerk's Notice of Judge Assignment and Optional Consent
Wed 09/29 3:59 PM
Clerks Notice of Judge Assignment to Judge Robin L. Rosenberg. (mc) |
||
transfer
MDL Tag-Along/Transfer In Case Receipt
Wed 09/29 4:05 PM
MDL Transfer In Case Receipt from Eastern District of Tennessee. Case Number 1:21-cv-00210 with documents 1-6. Assigned FLSD Case Number 9:21-cv-81833-RLR Davidson v. Boehringer Ingelheim Pharmaceuticals, Inc. et al on 9/29/2021. Re: FLSD MDL Case Number 9:20-md-02924-RLR pursuant to Conditional Transfer Order 77. Clerks Note: JPML notified (mc) |
||
Tuesday, September 28, 2021 | ||
6 | 6 CONDITIONAL TRANSFER ORDER (CTO-77) transferring case to the Southern District of Florida. (GRE) | |
5 | 5 RELATED CASE ORDER Signed by Magistrate Judge Susan K Lee on 9/28/21. (GRE) | |
District Judge Travis R McDonough and Magistrate Judge Susan K Lee added. (GRE) | ||
Friday, September 10, 2021 | ||
4 | 4 NOTICE of Deficiency (Pro Hac) to William Matthew Pettit: Attorney is not admitted (See LR 83.5). This matter will be referred to a magistrate judge if a pro hac motion is not filed within 15 days of this Notice. A form motion can be foundhere: https://www.tned.uscourts.gov/forms/motion-admission-pro-hac-vice. (ABF) | |
3 | 3 Certificate of Corporate Interest by Boehringer Ingelheim Pharmaceuticals, Inc.. (Etchells, Kelly) | |
Case referred to Judge Lee for a related case determination (see 1:21-cv-24). (GRE) | ||
Thursday, September 09, 2021 | ||
2 | 2 Certificate of Corporate Interest by GlaxoSmithKline, LLC identifying Corporate Parent GlaxoSmithKline plc for GlaxoSmithKline, LLC. (Powers, K) | |
1 | 1 NOTICE OF REMOVAL from Hamilton Co., TN Circuit, case number 20C918. (Filing fee $ 402 receipt number ATNEDC-4838775), filed by Boehringer Ingelheim Pharmaceuticals, Inc..(Etchells, Kelly) | |
Att: 1 Civil Case Coversheet, | ||
Att: 2 Exhibit A, | ||
Att: 3 Exhibit B part 1, | ||
Att: 4 Exhibit B part 2, | ||
Att: 5 Exhibit B part 3, | ||
Att: 6 Exhibit B part 4, | ||
Att: 7 Exhibit C |